US private equity firm SK Capital Partners is nearing a deal to acquire Swiss drug distribution company Swixx Biopharma SA, according to people familiar with the matter.
Share
Read more
Bloomberg - Where voices unite, stories flourish, and community thrives through open dialogue and meaningful connections.
Company
Trending
Categories
© Bloombergnews. All rights resereved